Nintedanib effect leading to cell cycle arrest was confirmed in vivo, as shown by decreased Cyclin D1 levels and proliferation rate of tumor cells in PC3 xenografts, which contributes to reduced tumor volume in animals that received the drug. This evidence concerns the gene CCND1 and neoplasm.